Brightsurf Science News & Current Events

July 18, 2004
Donepezil may have short-term benefit for mild cognitive impairment
People with mild cognitive impairment (MCI) taking the drug donepezil were at reduced risk of progressing to Alzheimer's disease (AD) for the first 18 months of a 3-year study when compared with their counterparts on placebo, according to a presentation of preliminary data from a recently completed clinical trial supported by the National Institute on Aging (NIA), part of the National Institutes of Health.

Alzheimer's Association, NIA seek to expedite prevention trials for Alzheimer's
Reducing the cost and complexity of Alzheimer's disease prevention trials would speed progress in testing new therapies, according to scientists at The 9th International Conference on Alzheimer's Disease and Related Disorders (ICAD), presented by the Alzheimer's Association in Philadelphia.

New research on causes of cancer patients' fatigue
Fatigue - a common problem in patients who are recovering from cancer - is associated with depression and reduced physical performance and not, as previously suggested, with anaemia, a flagging immune system or other physiological conditions according to research in Annals of Oncology.

Treatment causes short-term, modest delay in Alzheimer's onset in patients with mild cog impairment
For the first time, a drug appears to have a slowing effect -- though limited -- on the progression from mild cognitive impairment, a memory disorder considered a strong early predictor of Alzheimer's disease, to Alzheimer's.

No clear-cut answers on statins as therapy for Alzheimer's disease
Statins continue to generate interest as a possible preventive strategy for Alzheimer's disease, based on studies at The 9th International Conference on Alzheimer's Disease and Related Disorders (ICAD), presented by the Alzheimer's Association.

Early warnings signs may signal presence of mild cognitive impairment
Difficulties in performing more challenging cognitive tasks, such as managing one's finances and medications, preparing meals and traveling independently, could be early warning signs that indicate the presence of mild cognitive impairment (MCI), according to Emory University researchers.

Primate research combines with eye-tracking technology to detect cognitive impairment
Researchers at the Yerkes National Primate Research Center of Emory University have expanded a nonhuman primate (NHP)-based study to human patients with the intention of identifying human patients with mild cognitive impairment (MCI) who will progress to the more devastating Alzheimer's disease (AD).

New drugs prevent scarring after glaucoma eye surgery
Highly innovative new drugs that can prevent scarring in the eye after glaucoma surgery have been discovered by a London-based team of scientists, who report today in the journal Nature Biotechnology.

New research explores definition, incidence & treatment of Mild Cognitive Impairment (MCI)
Individuals with mild cognitive impairment (MCI) who took the Alzheimer drug donepezil had a reduced risk of progressing to Alzheimer's disease compared to those who took placebo, according to preliminary data reported today at the 9th International Conference on Alzheimer's Disease and Related Disorders (ICAD), presented by the Alzheimer's Association.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.